Nebilet | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Nebilet

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 15 USDMF, 11 CEP/COS, 8 EU WC, 13 KDMF, 8 NDC API, 30 Listed Suppliers

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

INTERMEDIATES

30 Intermediate Suppliers

30 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

344 FDF Dossiers, 80 FDA Orange Book, 152 Europe, 9 Canada, 42 Australia, 2 South Africa, 59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 5MG BASE;80MG, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 10 Gangwal Chemicals, 1 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 21 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 24 Direct Compression, 21 Granulation, 20 Controlled & Modified Release, 17 Disintegrants & Superdisintegrants, 15 Lubricants & Glidants, 14 Thickeners and Stabilizers, 13 Solubilizers, 12 Film Formers & Plasticizers, 12 Co-Processed Excipients, 10 Taste Masking, 9 Parenteral, 7 Emulsifying Agents, 7 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 6 Topical, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

27 News #PharmaBuzz

27 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 61 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

26 APIs, 5 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

6 Others

6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Filters

FILTER :

filter Product Reset all filters

5 All

01 1Bystolic

02 4Bystolic/Byvalson

List of Suppliers

Product Main Page

01

Brand Name : Bystolic/Byvalson

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Nebivolol HCl

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 614

2016 Revenue in Millions : 641

Growth (%) : -4

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Bystolic/Byvalson

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Nebivolol HCl

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 586

2017 Revenue in Millions : 614

Growth (%) : -5%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Bystolic/Byvalson

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Nebivolol HCl

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 641

2015 Revenue in Millions : 646

Growth (%) : -1

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Bystolic/Byvalson

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 603

2018 Revenue in Millions : 586

Growth (%) : 3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Bystolic

RDD

Not Confirmed

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.